key: cord-0014232-co4quvy4 authors: Ahamefule, Chukwuemeka Samson; Ezeuduji, Blessing C.; Ogbonna, James C.; Moneke, Anene N.; Ike, Anthony C.; Wang, Bin; Jin, Cheng; Fang, Wenxia title: Marine Bioactive Compounds against Aspergillus fumigatus: Challenges and Future Prospects date: 2020-11-16 journal: Antibiotics (Basel) DOI: 10.3390/antibiotics9110813 sha: f2883f52cbba79288a96661fa2d0a56a800fd5c9 doc_id: 14232 cord_uid: co4quvy4 With the mortality rate of invasive aspergillosis caused by Aspergillus fumigatus reaching almost 100% among some groups of patients, and with the rapidly increasing resistance of A. fumigatus to available antifungal drugs, new antifungal agents have never been more desirable than now. Numerous bioactive compounds were isolated and characterized from marine resources. However, only a few exhibited a potent activity against A. fumigatus when compared to the multitude that did against some other pathogens. Here, we review the marine bioactive compounds that display a bioactivity against A. fumigatus. The challenges hampering the discovery of antifungal agents from this rich habitat are also critically analyzed. Further, we propose strategies that could speed up an efficient discovery and broaden the dimensions of screening in order to obtain promising in vivo antifungal agents with new modes of action. Aspergillus fumigatus is a saprophytic mold commonly found in the environment, with spores that are very light and easily disseminated [1] . It is also a potentially dangerous opportunistic pathogen that is reported as being the number one causative mold for mycoses, especially in immunocompromised patients [2] . Invasive aspergillosis (IA) caused by A. fumigatus is a severe systemic infection with high mortality and morbidity rates. IA has an annual global incidence of over 200,000, and the mortality rate could reach almost 100% among certain categories of patients if not properly treated [2] [3] [4] . With the already existing challenge of having only a limited repertoire of antifungal drugs for the treatment of aspergilloses, the continuous rise of drug resistance in A. fumigatus strains [5] [6] [7] further aggravates this challenge. Reports of A. fumigatus developing a resistance, in both clinical [8, 9] and environmental [10, 11] isolates, to antifungal drugs such as amphotericin B [12] , azole-class drugs [13, 14] and echinocandins [5, 15] , as well as developing a multidrug resistance [16] , are increasing annually. In the UK for example, Public Health England reported over a five-fold increase in A. fumigatus isolates that showed resistance to itraconazole (Minimum Inhibitory Concentration (MIC) ≥ 2.0 µg/mL) very weak activity against A. fumigatus, with MICs of >64 µg/mL [83] . On the other hand, extracts from some streptomycetes [86, 87] , and other bacteria like Micrococcus sp., Flavobacterium sp. and Streptomyces sp. [64] , have also been demonstrated as possessing very effective activities against A. fumigatus (Table 2 ). More interestingly, some of these extracts also showed promising activities against A. fumigatus strains with multidrug resistance (MDR) ( Table 2 ). Marine sponges, such as Theonella swinhoei, Siliquariaspongia japonica and Microscleroderma herdmani, are other categories of interesting marine organisms demonstrated to produce effective antifungal compounds against A. fumigatus. Compounds such as Aurantosides E, A, B and Microsclerodermin B are the best antifungal bioactive compounds against A. fumigatus, with MICs of 0.04, 0.16, 0.16 and 0.6 µg/mL, respectively [77, 88] (Table 3 ; Figure 2 ). Moreover, other Microsclerodermins (A, J and K) and Swinhoeiamide A also exhibit a good antifungal activity against A. fumigatus, with MICs ranging between 1 to 10 µg/mL [77, 89] (Table 3 ). Both compounds and extracts from several marine algae have been demonstrated to exhibit antifungal activities against A. fumigatus. The bromophenol compound 2,20,3,30-tetrabromo-4,40,5,50-tetrahydroxydiphenylmethane is one of the most potent compounds from marine algae, with a potent activity against A. fumigatus (with an MIC of 0.78 µg/mL) [94] (Table 4 ; Figure 3 ). Furthermore, ethanol extracts from Laurencia majuscula and Padina pavonica displayed an effective activity against A. fumigatus at low MICs of 1.95 and 0.95 µg/mL, respectively [71] (Table 4 ). Several triterpene glycosides ( Figure 4 ) with good antifungal activities against A. fumigatus have been isolated and characterized from sea cucumbers such as Holothuria scabra, Actinopyga lecanora, several species of Bohadschia, etc. [80, 81, 96, 97] . Among the best bioactive compounds isolated from these marine echinoderms, potent activities with an MIC 80 ranging from 1.0 to 4.0 µg/mL have been recorded in in vitro screenings (Table 5 ). Triterpene glycosides therefore present very good prospects for future antifungal drug development. Besides characterized compounds, both crude and partially purified extracts from different sea cucumbers have also been demonstrated to exhibit varying levels of antifungal activities against A. fumigatus. Ismail et al. [79] reported that crude and semipurified extracts from both aqueous body fluid extracts and methanolic wall extracts from Holothuria polii displayed varying activities against A. fumigatus in a concentration-dependent manner. Methanolic body-wall crude extracts showed better activities than those of aqueous body fluid. However, there was no difference in activities among the extracts after purification. Similarly, Adibpour et al. [98] also recorded an antifungal activity against A. fumigatus from Holothuria leucospilota body-wall and coelomic fluid extracts but none from its cuvierian organs' extracts. A few studies have reported bioactive compounds from marine fungi against pathogenic molds. With reference to A. fumigatus, to the best of our knowledge, only the marine fungus Phoma sp. produced a characterized bioactive compound, YM-202204, with an IC 80 of 12.5 µg/mL against A. fumigatus [69] . We propose that most fungi do indeed produce necessary antagonism metabolites against their fellow fungi if "they feel threatened" or if there is competition. That is why we have proposed several enhanced pathways (e.g., the coculture approach) for isolating and screening bioactive compounds (Figures 5 and 6 ). One of the biggest challenges facing the discovery of effective antifungal agents against A. fumigatus and other pathogenic microorganisms from a rich marine environment is the limitation on culturable organisms. It has been proven that the vast majority of microorganisms in nature cannot be isolated through the usual cultural techniques and are therefore labelled as unculturable microorganisms [100, 101] , where marine microbes predominate. Therefore, obtaining these viable but unculturable marine microbes by using several methods, including molecular approaches [102] and simpler techniques such as a long incubation with low nutrition [101] , will certainly open a new vista of opportunities for discovering new antimicrobial agents. This may consequently lead to obtaining and evaluating novel metabolites from those unisolated and uncharacterized microorganisms, increasing the possibility of discovering potent antimicrobials, including antifungal agents against A. fumigatus ( Figure 5) . Furthermore, the techniques and methods currently adopted in the isolation and screening of these bioactive compounds require upgrading in order to increase the chances of identifying new broad spectrum antimicrobial agents. For example, mainly focusing on extracellular components from these marine microorganisms seriously limits the global progress in this search. Considering the fact that marine organisms are unique, with special cellular features and components to survive in extreme and peculiar environments, it will be desirable to isolate and test intracellular and membrane-bound polysaccharides, peptides and lipids [103, 104] . Moreover, conducting an initial screening of these compounds with predominantly in vitro assays might just be another limitation in this search. It has previously been demonstrated that certain compounds with weak in vitro antimicrobial activities could still be quite effective in in vivo applications [105] [106] [107] [108] . Such compounds could have alternative mechanisms of "conquering the pathogen(s) of interest" beyond biocidal/biostatic activities. Other mechanisms than just the usual growth inhibition of pathogens, such as the modulation of the host immune system or blocking the production of virulence factor(s), are enviable attributes of new compounds that can only be discovered with in vivo assays [107] [108] [109] [110] . Therefore, in vivo screening assays are highly recommended to discover bioactive compounds with broader modes of action. Using invertebrate models such as Caenorhabditis elegans for a high-throughput in vivo screening has numerous advantages, including the absence of an ethical license requirement, reduced cost, labor and resources, as well as the possibility to simultaneously determine the cytotoxity of bioactive compounds [105, 110] . We have recently established a C. elegans-based A. fumigatus infection model [111] , making the high-throughput evaluation of the efficacy of bioactive compounds possible. Furthermore, we also discovered that the in vivo efficacy of some antifungal agents was different from what was observed in in vitro screenings, as demonstrated by the different killing modes of amphotericin B and the azole drugs. These therefore provide confidence in high-throughput in vivo assays as the primary screening approach. Based on the general numbers of bioactive compounds from marine microbes, there are multiple strategies for inducing the production of some essential bioactive metabolites that possess antifungal properties, such as coculturing marine microbes with stimulators (other microorganisms, pathogens/their metabolites) or exposing them to stress conditions. Heavy metal stress could induce the expression of genes that lead to the production of desired metabolites, some of which have also been discovered to possess antimicrobial properties [112] [113] [114] [115] [116] . The use of heavy metals in the culture media of certain marine organisms is necessary for inducing the production of some essential metabolites, which may have antifungal properties. Evaluating such antifungal potency on A. fumigatus would really help to broaden the future search and discovery of antimicrobial compounds. We have therefore suggested cultural approaches in Figure 6 in order to broaden and hasten the search for antifungal agents against A. fumigatus. Six culture approaches, ranging from monocultures to cocultures under different conditions, are suggested to stimulate genes involved in the production of uncommon metabolites, thereby increasing the possibilities of finding novel bioactive compounds that may otherwise not be identified through conventional approaches. The search for antifungal agents effective against A. fumigatus from the marine habitat has not been all that productive (compared to other similar leading opportunistic pathogens like Candida albicans) for years now. A change of strategy is therefore indispensable and urgent if we must win the raging menacing war against this mold pathogen. Adoption of alternative cultural methods and evaluation of compounds for other treatment mechanisms would help to broaden the horizon of this search and may as well just be the needed breakthrough that we are waiting for. Aspergillus fumigatus and aspergillosis in 2019 Azole-induced cell wall carbohydrate patches kill Aspergillus fumigatus Invasive aspergillosis Invasive aspergillosis in patients following umbilical cord blood transplant Chitin synthases with a myosin motor-like domain control the resistance of Aspergillus fumigatus to echinocandins High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a spe-cialist cardio-thoracic centre Airborne Aspergillus fumigatus spore concentration during demolition of a building on a hospital area and patient risk determination for invasive aspergillosis including azole resistance Triazole resistance in Aspergillus fumigatus isolates from patients with cystic fibrosis in Italy Non-cyp51A azole-resistant Aspergillus fumigatus isolates with mutation in HMG-CoA reductase A novel environmental azole resistance mutation in Aspergillus fumigatus and a possible role of sexual reproduction in its emergence Azole-resistant Aspergillus fumigatus in the Italian environment Widespread amphotericin B-resistant strains of Aspergillus fumigatus in Hamilton A novel Zn2 Cys6 transcription factor AtrR plays a key role in an azole resistance mechanism of Aspergillusfumigatus by co-regulating cyp51A and cdr1B expressions Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations Identification of a key lysine residue in heat shock protein 90 required for azole and echinocandin resistance in Aspergillus fumigatus Multidrug-resistant Aspergillus fumigatus carrying mutations linked to environmental fungicide exposure-Three states English Surveillance Programme for Antimicrobial Utilization and Resistance (ESPAUR) Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates Antibacterial and antiyeast compounds from marine-derived bacteria Antibacterial activities of bacteria isolated from the marine sponges Isodictya compressa and Higginsia bidentifera collected from Algoa Bay, South Africa Antioxidant activity of marine algal polyphenolic compounds: A mechanistic approach Production and bioactivity-guided isolation of antioxidants with α-glucosidase inhibitory and anti-NO properties from marine chitinous materials Sterols from Mytilidae show anti-aging and neuroprotective effects via anti-oxidative activity Chemical screening identifies an extract from marine Pseudomonas sp.-PTR-08 as an anti-aging agent that promotes fission yeast longevity by modulating the Pap1-ctt1 + pathway and the cell cycle Marine organisms with anti-diabetes properties Antihyperglycemic and antioxidant activities of a lectin from the marine red algae, Bryothamnion seaforthii, in rats with streptozotocin-induced diabetes Marine resources effective in controlling and treating diabetes and its associated complications Genomics of economically significant Aspergillus and Fusarium species On the parasitic vegetable structures found growing in living animals Aspergillosis in the 'nonimmunocompromised' host Craniocerebral aspergillosis of sinonasal origin in immunocompetent patients: Clinical spectrum and outcome in 25 cases Diagnostic MR imaging features of craniocerebral aspergillosis of sino-nasal origin in immunocompetent patients Chronic invasive sinus aspergillosis in immunocompetent hosts: A geographic comparison Orbital aspergillosis in immunocompetent patients Isolated orbital aspergillosis in immunocompetent patients: A multicenter study Invasive orbital apex aspergillosis with mycotic aneurysm formation and subarachnoid hemorrhage in immunocompetent patients Fatal Invasive aspergillosis and coronavirus disease in an immunocompetent patient Intracranial aspergillosis amongst immunocompetent patients: An experience with combined surgical and medical management of 18 patients Central nervous system aspergillosis in immunocompetent patients: Case series and literature review Pulmonary aspergillosis in immunocompetent patients without air-meniscus sign and underlying lung disease: CT findings and histopathologic features Invasive pulmonary aspergillosis in immunocompetent patients hospitalised with influenza A-related pneumonia: A multicenter retrospective study Adrenal and hepatic aspergillosis in an immunocompetent patient Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles Microbe profile: Aspergillus fumigatus: A saprotrophic and opportunistic fungal pathogen. Microbiology Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus: Should we be concerned? Antifungal efficacy of bacteria isolated from marine sedentary organisms The sponge-associated bacterium Bacillus licheniformis SAB1: A source of antimicrobial compounds A new macrolactam derivative from the marine actinomycete HF-11225 Bioactivities and extract dereplication of Actinomycetales isolated from marine sponges Marine rare actinomycetes: A promising source of structurally diverse and unique novel natural products YM-202204, a new antifungal antibiotic produced by marine fungus Phoma sp Isolation of haloalkaliphilic fungi from Lake Magadi in Kenya Antimicrobial, antioxidant and anticancer activities of Laurencia catarinensis, Laurencia majuscula and Padina pavonica extracts Biological activities of the red algae Galaxaura rugosa and Liagora hawaiiana butters The antifungal activity of extracts of Osmundea pinnatifida, an edible seaweed, indicates its usage as a safe environmental fungicide or as a food additive preventing post-harvest fungal food contamination Amphidinol 22, a new cytotoxic and antifungal amphidinol from the dinoflagellate Amphidinium carterae Antifungal activity of marine sponge Haliclona exigua (Krikpatrick) The marine sponge-derived polyketide endoperoxide plakortide F acid mediates its antifungal activity by interfering with calcium homeostasis Antifungal cyclic peptides from the marine sponge Microscleroderma herdmani Antifungal and antibacterial activity of Haliclona sp. from the Persian Gulf A activity of aqueous and methanolic extracts from the Mediterranean sea cucumber, Holothuria polii Antifungal triterpene glycosides from the sea cucumber Bohadschia marmorata Antifungal triterpene glycosides from the sea cucumber Holothuria (Microthele) axiloga Tupuseleiamides and basiliskamides, new acyldipeptides and antifungal polyketides produced in culture by a Bacillus laterosporus isolate obtained from a tropical marine habitat New ikarugamycin derivatives with antifungal and antibacterial properties from Streptomyces zhaozhouensis MDN-0170, a new napyradiomycin from Streptomyces sp. strain CA-271078 Structure elucidation and biosynthetic gene cluster analysis of caniferolides A-D, new bioactive glycosylated 36-membered polyol macrolides from the marine-derived Streptomyces caniferus CA-271066 Antifungal activity of Streptomyces VITSVK5 spp. against drug resistant Aspergillus clinical isolates from pulmonary tuberculosis patients Diversity and exploration of bioactive marine actinomycetes in the Bay of Bengal of the Puducherry coast of India New antifungal tetramic acid glycosides from the marine sponge Siliquariaspongia japonica Swinhoeiamide A, a new highly active calyculin derivative from the marine sponge Theonella swinhoei New bioactive peroxides from marine sponges of the family Plakiniidae Antifungal effect and possible mode of activity of a compound from the marine sponge Dysidea herbacea Antineoplastic agents. 257. Isolation and structure of spongistatin 1 A broad-spectrum antifungal from the marine sponge Hyrtios erecta Antimicrobial activities of the bromophenols from the red alga Odonthalia corymbifera and some synthetic derivatives New antifungal cholestane and aldehyde derivatives from the red alga Laurencia papillosa Antifungal activity in triterpene glycosides from the sea cucumber Actinopyga lecanora Antifungal active triterpene glycosides from sea cucumber Holothuria scabra Antibacterial and antifungal activity of Holothuria leucospilota isolated from Persian Gulf and Oman Sea Antifungal activity of bivittoside-D from Bohadschia vitiensis (Semper) The value of cultures to modern microbiology Isolation of uncultured bacteria from Antarctica using long incubation periods and low nutritional media Challenges of unculturable bacteria: Environmental perspectives Naturally drug-loaded chitin: Isolation and applications Collagen of extracellular matrix from marine invertebrates and its medical applications Antifungal chemical compounds identified using a C. elegans pathogenicity assay High-throughput screen for novel antimicrobials using a whole animal infection model Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans Inhibitory effects of the essential oils α-longipinene and linalool on biofilm formation and hyphal growth of Candida albicans Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay Caenorhabditis elegans in high-throughput screens for anti-infective compounds Caenorhabditis elegans-based Aspergillus fumigatus infection model for evaluating pathogenicity and drug efficacy Arousing sleeping genes: Shifts in secondary metabolism of metal tolerant actinobacteria under conditions of heavy metal stress Divalent transition-metal-ion stress induces prodigiosin biosynthesis in Streptomyces coelicolor M145: Formation of coeligiosins Stress-driven discovery of a cryptic antibiotic produced by Streptomyces sp. WU20 from Kueishantao hydrothermal vent with an integrated metabolomics strategy Production of an antibiotic enterocin from a marine actinobacteria strain H1003 by metal-stress technique with enhanced enrichment using response surface methodology System for the heterologous expression of NS1 protein of H9N2 avian influenza virus in the ciliate Tetrahymena thermophila Publisher's Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.